Finance

Beta
Lists
PHAR:NASDAQ
Pharming Group NV - ADR
$12.80
-0.58%
(-0.075) 1D
$12.50
-2.38% (-0.31)
After hours
Closed: Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAR...
Open
$12.70
High
$12.98
Low
$12.70
Mkt. cap
785.64M
Avg. vol.
14.03K
Volume
6.85K
52-wk high
$21.30
52-wk low
$9.28
Beta
-0.03
Shares outstanding
70.63M
No. of employees
407
Open
$12.70
High
$12.98
Low
$12.70
Mkt. cap
785.64M
Avg. vol.
14.03K
Volume
6.85K
52-wk high
$21.30
52-wk low
$9.28
Beta
-0.03
Shares outstanding
70.63M
No. of employees
407
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to PHAR in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PHAR in the last 3 months.
Highest
Current $12.80
$40.00 (+212.38%)
Average
$38.00 (+196.76%)
Lowest
$37.00 (+188.95%)
News stories
From sources across the web
About Pharming Group NV - ADR
CEO-
Employees407
Founded1988
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
93.22M
97.29M
106.53M
72.45M
Cost of goods sold
8.97M
7.07M
21.13M
6.64M
Cost of revenue
8.97M
7.07M
21.13M
6.64M
Research and development expenses
25.80M
21.28M
32.05M
25.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57.25M
43.08M
50.67M
45.53M
Operating expense
81.20M
64.29M
82.37M
70.71M
Total operating expenses
90.17M
71.36M
103.50M
77.36M
Operating income
3.05M
25.92M
3.03M
-4.91M
Other non operating income
-738.00K
1.88M
403.00K
-
EBT including unusual items
7.08M
12.76M
4.80M
-4.75M
EBT excluding unusual items
-721.00K
22.86M
1.61M
-4.75M
Income tax expense
2.53M
5.21M
-528.00K
459.00K
Effective tax rate
35.73%
40.83%
-11.00%
-9.65%
Other operating expenses
-1.85M
-71.00K
-348.00K
-377.00K
Net income
4.69M
7.55M
5.33M
-5.21M
Net profit margin
5.04%
7.76%
5.00%
-7.20%
Earnings per share
0.01
0.01
0.01
-0.07
Interest and investment income
1.26M
-
4.50M
3.24M
Interest expense
-4.00K
-9.21M
-
-2.70M
Net interest expenses
1.26M
-9.21M
4.50M
542.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
4.28M
30.12M
6.24M
-1.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more